VeriMom¿Es oligopeptide-20 seguro durante el embarazo?
No harmonised CLP classification on reproductive toxicity (ECHA Annex VI), no CIR or SCCS safety assessment flagging reproductive risk, and no peer‑reviewed reports of teratogenic or reproductive effects for oligopeptide‑20. As a synthetic oligopeptide (large, hydrophilic), dermal systemic absorption from cosmetic use is expected to be negligible, so exposure in pregnancy from topical use is essentially negligible (sources: ECHA Annex VI; CosIng; PubChem; PubMed search found no reproductive/toxicology reports).
Pregnancy-safe products containing oligopeptide-20
Related ingredients
Frequently asked questions
- ¿Es oligopeptide-20 seguro durante el embarazo?
- No harmonised CLP classification on reproductive toxicity (ECHA Annex VI), no CIR or SCCS safety assessment flagging reproductive risk, and no peer‑reviewed reports of teratogenic or reproductive effects for oligopeptide‑20. As a synthetic oligopeptide (large, hydrophilic), dermal systemic absorption from cosmetic use is expected to be negligible, so exposure in pregnancy from topical use is essentially negligible (sources: ECHA Annex VI; CosIng; PubChem; PubMed search found no reproductive/toxicology reports).
- ¿Es oligopeptide-20 seguro durante la lactancia?
- No evidence of reproductive or lactation-related hazards in authoritative sources (no harmonised classification, no CIR/SCCS concerns, no peer‑reviewed data indicating transfer into milk). With negligible dermal absorption from topical cosmetic use, systemic exposure (and thus transfer into breastmilk) is expected to be negligible (sources: ECHA Annex VI; CosIng; PubChem; PubMed).
- ¿Es oligopeptide-20 seguro para la piel del bebé?
- No evidence of developmental/infant toxicity or mechanistic reproductive hazard. However, because infant skin has a less mature barrier and higher surface‑area‑to‑weight, a conservative increase in exposure rating is applied (+1) despite peptide’s generally poor dermal penetration; adult systemic exposure is expected negligible, but infant exposure potential is low but measurable for topical application (sources: general dermal absorption principles, CosIng, PubChem; no infant‑specific studies found in PubMed).
- ¿Cómo puntúa VeriMom a oligopeptide-20?
- VeriMom puntúa oligopeptide-20 en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a oligopeptide-20 en el embarazo?
- Consulta nuestra lista de alternativas seguras a oligopeptide-20 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.